KD Logo

Dyne Therapeutics Inc [DYN] Officer makes an insider purchase of 1,390 shares worth 47964.0.

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Dyne Therapeutics Inc shares valued at $47,964 were purchased by Scalzo Richard William on Sep 18 ’24. At $34.51 per share, Scalzo Richard William acquired 1,390 shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Beskrovnaya Oxana purchased 2,339 shares, netting a total of over 80,715 in proceeds.

Before that, McNeill Jonathan had added 1,870 shares to its account. In a trade valued at $64,528, the Officer bought Dyne Therapeutics Inc shares for $34.51 each.

As published in a research note from Chardan Capital Markets on May 21, 2024, Dyne Therapeutics Inc [DYN] has been retained to a Buy and the price target has been revised to $42. Analysts at Morgan Stanley started covering the stock with ‘”an Overweight”‘ outlook in a report released in late April. As of February 20, 2024, H.C. Wainwright has initiated its “Buy” rating for DYN. Earlier on February 27, 2023, Raymond James upgraded its rating. Their new recommendation was “a Strong buy” for DYN stock which previously was a “an Outperform”.

Analyzing DYN Stock Performance

During the last five days, there has been a surge of approximately 5.34%. Over the course of the year, Dyne Therapeutics Inc shares have jumped approximately 158.20%. Shares of the company reached a 52-week high of $47.45 on 08/20/24 and a 52-week low of $12.33 on 01/03/24. A 50-day SMA is recorded $41.15, while a 200-day SMA reached $28.59. Nevertheless, trading volume fell to 1.06 million shares from 1.21 million shares the previous day.

Support And Resistance Levels for Dyne Therapeutics Inc (DYN)

According to the 24-hour chart, there is a support level at 33.84, which, if violated, would cause prices to drop to 33.33. In the upper region, resistance lies at 35.06. The next price resistance is at 35.77. RSI (Relative Strength Index) is 37.69 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.67, which suggests the price will decrease in the coming days. Percent R is at 52.48%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular